Candesartan vs Erlotinib

Candesartan vs Erlotinib: Overview

This comparison examines the pharmacological differences between Candesartan and Erlotinib.

Mechanism of Action

Candesartan: Prodrug hydrolyzed to active form; selective angiotensin II type 1 receptor blocker.

Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

Pharmacokinetics

Half-life: Candesartan — 9 hours; Erlotinib — 36 hours.

Chemical Properties

Molecular Formula: Candesartan — C33H34N6O6; Erlotinib — C22H23N3O4.

Molecular Weight: Candesartan — 610.6640 g/mol; Erlotinib — 393.4380 g/mol.

Type: Candesartan — Small molecule; Erlotinib — Small molecule.